Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study. (Q46912365)
Jump to navigation
Jump to search
scientific article published in April 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study. |
scientific article published in April 2002 |
Statements
Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study (English)
Celeste L Pearce
Laurence N Kolonel
Nick M Makridakis
Ronald K Ross
Malcolm C Pike
Brian E Henderson